Skip to main content
glpverdict
Editorial medical reviewFDA & peer-reviewed sourcesUpdated weeklyMedically reviewed content
HomeCompareRybelsus vs Saxenda

Medication comparison

Rybelsus vs Saxenda

Rybelsus and Saxenda are both prescription medications (GLP-1 receptor agonist (oral tablet) vs GLP-1 receptor agonist (daily injection)) used for Type 2 diabetes and Chronic weight management (adults + adolescents 12+). The table below compares FDA-approved indications, dosing, weight-loss outcomes, side effects, contraindications, and current pricing — all sourced from the manufacturer prescribing information.

Find a provider for Rybelsus or Saxenda

Affiliate disclosure: we earn commission on signups. Editorial ranking stays independent.

This is general drug information, not medical advice. Talk to a licensed clinician before starting, stopping, or switching medication.

Top 3 providers prescribing Rybelsus or Saxenda

Affiliate links — we earn commission on conversions; editorial ranking is independent.

Overview

PropertyRybelsusSaxenda
Generic namesemaglutide (oral)liraglutide
Drug classGLP-1 receptor agonist (oral tablet)GLP-1 receptor agonist (daily injection)
ManufacturerNovo NordiskNovo Nordisk
Brand namesRybelsusSaxenda

Approved uses

PropertyRybelsusSaxenda
Approved indicationsType 2 diabetesChronic weight management (adults + adolescents 12+)

Dosing

PropertyRybelsusSaxenda
Typical dosing

Side effects & warnings

PropertyRybelsusSaxenda
Top side effects
Contraindications
Boxed warningNoNo

Special populations

PropertyRybelsusSaxenda
Pregnancy

Storage

PropertyRybelsusSaxenda
Storage

Cost

PropertyRybelsusSaxenda
Avg monthly cost$1029.00$1349.00

Frequently asked

What is the difference between Rybelsus and Saxenda?

Rybelsus is semaglutide (oral) (GLP-1 receptor agonist (oral tablet)) and Saxenda is liraglutide (GLP-1 receptor agonist (daily injection)). They have different active ingredients and slightly different side-effect profiles.

Is Rybelsus or Saxenda more effective for weight loss?

See each drug's clinical-trials section for the registrational outcome data (SURMOUNT for tirzepatide; STEP for semaglutide; SCALE for liraglutide). Average weight loss varies by trial duration, dose ceiling, and adherence.

Can I switch between Rybelsus and Saxenda?

Switching between GLP-1 medications requires re-titration when crossing active ingredients (semaglutide ↔ tirzepatide). Always coordinate with your prescriber before switching.

Other GLP-1 head-to-head comparisons

More medication context

Tools and guides that pair with this comparison.

Affiliate disclosure: we earn commissions when readers sign up through our links. Editorial ranking is independent.